ArticleEuropean journal of cancer (Oxford, England : 1990)2025

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine.

Karin P S Langenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.